We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Hiran Orgochem Ltd. (Symbol:506170) SWOT Analysis, Strategy, Revenues and Profits

Hiran Orgochem Ltd. (Symbol:506170) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Hiran Orgochem Ltd. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Philippines, Asia, Singapore, Indonesia, Bangladesh, Yemen, Vietnam, South Korea, Pakistan, Malaysia, Jordan, Japan, Israel, India

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

CCM Duopharma Biotech Bhd. (CCMDBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary CCM Duopharma Biotech Bhd. (CCM Duopharma) is an investment holding company. The company conducts manufacturing, distributing, importing, and exporting of pharmaceutical products and medicines. It offers products that include analgesic and anti-pyretics, oral antibiotics, cough preparations, ...

Industries: Drug and Medication | Countries: Yemen, Asia, Papua New Guinea, Sri Lanka, Singapore, Bangladesh

Taisho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review

Taisho Pharmaceutical Co., Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

Summary Taisho Pharmaceutical Co., Ltd. (Taisho) is a pharmaceutical company. The company carries out the development, manufacture and marketing of various pharmaceutical products. Its products include a range of prescription pharmaceutical and self-medication drugs. Taisho's products include pabron, ...

Industries: Pharmaceutical | Countries: Philippines, Japan, United States, Australia, Indonesia, Asia, Vietnam, Thailand, Taiwan, Malaysia, China

TAD Pharma GmbH SWOT Analysis, Strategy, Revenues and Profits

TAD Pharma GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: Switzerland, Europe, Portugal, Ireland, Hungary, Greece, Germany, Cyprus, Austria, Albania, Yemen, Taiwan, Syrian Arab Republic, Lebanon, Jordan, China, Asia

Asia-Pacific Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

Asia-Pacific Clinical Data Analytics In Healthcare - Growth, Trends And Forecasts (2014 - 2019)

  • $ 1 000
  • Industry report
  • by Mordor Intelligence LLP
  • September 2014

Big Data is the new buzzword in Healthcare industry. Experts are now realizing its benefits and adopting different solutions as per the requirements. One such solution which is seeing a high adoption rate is Clinical Data Analytics. New electronic health record systems and health information exchanges ...

Industries: Drug Discovery and Development | Countries: Asia

Asia Pacific NIPT Market Outlook 2018

Asia Pacific NIPT Market Outlook 2018

  • $ 1 400
  • Industry report
  • by RNCOS
  • September 2014
  • 55 pages

Non-Invasive Prenatal Testing (NIPT) has catapulted growth in the molecular diagnostics market. In the US, where the test was initially launched, the market is expected to grow at a CAGR of 49% during 2013-2018. However, owing to a restrictive potential population base in USA, which is estimated at around ...

Industries: Drug Discovery and Development | Countries: Australia, India, Japan, China, Asia, World, Oceania

Asia-Pacific Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

Asia-Pacific Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

  • $ 1 250
  • Industry report
  • by Mordor Intelligence LLP
  • August 2014

The Asia Pacific market is the fastest growing market for anticoccidials. This is primarily due to the increased demand for meat protiens in countries like China, India, Malaysia etc. The increased demand for meat proteins has increased the meat production in the region. China is the leading contributo ...

Industries: Drug and Medication | Countries: China, World, India, Asia, Australia, Malaysia, Japan

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • August 2014
  • 114 pages

BMI View: Hong Kong was in the past an attractive commercial prospect, largely propped by the widespread use of patented medicines. However, the climate of cost-containment over the past decade represents and the rising prominence of the pharmaceutical industry of mainland China have somewhat diminished ...

Industries: Drug and Medication | Countries: China, United States, Asia

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

  • $ 4 995
  • Industry report
  • by GBI Research
  • August 2014
  • 105 pages

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM Summary GBI Research, the leading business intelligence provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in ...

Industries: Therapy | Countries: Australia, India, Japan, China, World, United States, Asia, Oceania

Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • by TBRC Business Research
  • August 2014
  • 19 pages

The Oncology Research Digest is a digest of all the most important research in the oncology market each quarter, and available as an annual subscription. It covers areas such as biosimilars, novel immunotherapies, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian cance ...

Industries: Pathology | Countries: China, World, United States, India, Asia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.